You pursued a career in medicine to solve healthcare challenges, to serve people, and to save lives.
Yet in today’s unprecedented pace of innovations in medicine it is challenging to remain up-to-date on the treatment advancements that could improve your patient lives and benefit their families for years to come.
Nexus Oncology provides you with the most critical information you need to bring the best options in cancer care to your patients.
Nexus Oncology's decades of Oncology expertise leverages our experience to address your challenges and patient concerns. We are committed to ensuring that you have the most up-to-date clinical information to make the best decisions for patients in your care.
We are disrupting medical education by offering unbiased, non-promotional clinical treatment advances and data results with innovative insights at your fingertips, as well as, detailed perspective reports, private interviews, video vignettes, seminars, small table formats, and conference presence.
Our clinical updates inform you quickly so that you can offer the best in cancer innovations to impact patient outcomes.
We partner with the most prolific and well-known oncology experts providing authenticity and credibility while ensuring that our unrivaled Nexus Network of community and academic physicians become current with the ever-changing oncology landscape.
Oncologists’ “Go-To” channel for up-to-date clinical data broken down by the experts in the disease.
Nexus Oncology is the “go-to” resource for physicians. We deliver the latest in innovation and information when and where you need it.
All the information you need to keep up to date with oncology events, conferences, seminars and more.
In the United States, there are over 60,000 new diagnoses and nearly 14,000 deaths from kidney cancer each year. The treatment landscape is quickly evolving. Join us to learn more...
With therapeutic advances in lung cancer coming fast and furious, hear from recognized lung cancer experts on how the treatment landscape is evolving. Must be a healthcare professional to attend.
The Who, When, Where, and How of PARP Inhibition. Linking the biology, the disease, and the treatment.
With therapeutic advances in lung cancer coming fast and furious, hear from recognized lung cancer experts on how the treatment landscape is evolving. Must be a healthcare professional to attend.
In the United States, there are over 60,000 new diagnoses and nearly 14,000 deaths from kidney cancer each year. The treatment landscape is quickly evolving. Join us to learn more...
Contact us to join our network, learn more about our educational offerings, or inquire about joining our faculty. We are your source for up-to-date clinical information.
GET IN TOUCH
